cyclin-d1 and Chagas-Disease

cyclin-d1 has been researched along with Chagas-Disease* in 3 studies

Other Studies

3 other study(ies) available for cyclin-d1 and Chagas-Disease

ArticleYear
Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts.
    Cell cycle (Georgetown, Tex.), 2008, Feb-15, Volume: 7, Issue:4

    Infection with the parasite Trypanosoma cruzi causes Chagas disease. In this study we demonstrated that there was an increase in cyclin D1 expression in T. cruzi (Tulahuen strain)-infected myoblasts. To examine a possible mechanism for the increased cyclin D1 expression we transfected L(6)E(9) myoblasts with cyclin D1 luciferase reporter constructs and infected with T. cruzi. There was no evidence of an increase in promoter activity. Additionally, quantitative PCR did not demonstrate any change in cyclin D1 message during infection. Moreover, we demonstrated that the cyclin D1 protein was significantly stabilized after infection. Collectively, these data indicate that infection with T. cruzi increases cyclin D1 protein abundance post-translationally.

    Topics: Animals; Chagas Disease; Cyclin D1; DNA Primers; Gene Expression Regulation; Humans; Luciferases; Myoblasts; Trypanosoma cruzi

2008
Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells.
    Infection and immunity, 2006, Volume: 74, Issue:1

    Trypanosoma cruzi infection causes cardiomyopathy and vasculopathy. Previous studies have demonstrated that infection of human umbilical vein endothelial and smooth muscle cells resulted in activation of extracellular signal-regulated kinase (ERK). In the present study, smooth muscle cells were infected with trypomastigotes, and immunoblot analysis revealed an increase in the expression of cyclin D1 and proliferating cell nuclear antigen (PCNA), important mediators of smooth muscle cell proliferation. Interestingly, after infection, the expression of caveolin-1 was reduced in both human umbilical vein endothelial cells and smooth muscle cells. Immunoblot and immunohistochemical analyses of lysates of carotid arteries obtained from infected mice revealed increased expression of PCNA, cyclin D1, its substrate, phospho-Rb (Ser780), and phospho-ERK1/2. The expression of the cyclin-dependent kinase inhibitor p21(Cip1/Waf1), caveolin-1, and caveolin-3 was reduced in carotid arteries obtained from infected mice. There was an increase in the abundance of pre-pro-endothelin-1 mRNA in the carotid artery and aorta from infected mice. The ET(A) receptor was also elevated in infected arteries. ERK activates endothelin-1, which in turn exerts positive feedback activating ERK, and cyclin D1 is a downstream target of both endothelin-1 and ERK. There was significant incorporation of bromodeoxyuridine into smooth muscle cell DNA when treatment was with conditioned medium obtained from infected endothelial cells. Taken together, these data suggest that T. cruzi infection stimulates smooth muscle cell proliferation and is likely a result of the upregulation of the ERK-cyclin D1-endothelin-1 pathway.

    Topics: Animals; Bromodeoxyuridine; Carotid Arteries; Caveolins; Cell Cycle; Cell Proliferation; Cells, Cultured; Chagas Disease; Cyclin D1; Endothelial Cells; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Mice; Mice, Inbred A; Mice, Inbred C3H; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Receptor, Endothelin A; RNA Precursors; Trypanosoma cruzi

2006
Cytogenetic alterations in chagasic achalasia compared to esophageal carcinoma.
    Cancer genetics and cytogenetics, 2004, Volume: 149, Issue:1

    Patients with chagasic achalasia (megaesophagus) are liable to have an additional 1.7-20% possibility of developing esophageal squamous cell carcinoma (ESCC). We applied a fluorescence in situ hybridization technique in 20 such patients and found aneuploidies of chromosomes 7, 11, and 17 in 60% (12 of 20 specimens) and deletion of the TP53 gene in 54.5% (6 of 11 specimens; it was only possible to obtain data by FISH technique from 11 of the 20 achalasia patients). The main aneuploidies detected were chromosome 7 monosomy or trisomy (35%) in mid-third megaesophagus cases, and chromosome 17 monosomy or trisomy (25%) in distal-third cases. TP53 gene deletion was more frequent in mid-third (62.5%) than in distal-third megaesophagus cases (40%). In chagasic megaesophagus, no amplification of the cyclin D1 gene (CCND1) was observed. Comparing chagasic megaesophagus to ESCC, we found a higher frequency of aneuploidies in all 10 tumors. The main alterations were trisomy or tetrasomy of chromosomes 17 (90%), 11 (70%), and 7 (70%). Amplification of CCND1 was evidenced as a cluster in 70% of the tumors (22-99% of nuclei), while TP53 gene deletion occurred in 100%. To our knowledge, this is the first cytogenetic analysis of chagasic megaesophagus to show that aneuploidies of chromosomes 7, 11, and 17, and TP53 gene deletion might be related to increased risk for malignancy.

    Topics: Adult; Aged; Aneuploidy; Carcinoma, Squamous Cell; Chagas Disease; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 7; Cyclin D1; Esophageal Achalasia; Esophageal Neoplasms; Female; Gene Deletion; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Monosomy; Trisomy; Tumor Suppressor Protein p53

2004